Clinical Trial Update: The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines [Phase 3]

View source ↗

Summary

Phase 3 study comparing Protoxin to Botox in adults with moderate to severe glabellar lines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• Protoxin

Snippet

Sponsor: Protox Inc. | Conditions: Glabellar Frown Lines | Phase 3 | Status: COMPLETED